Mirvetuximab [1453084-36-0]

Référence T76766-1mg

Conditionnement : 1mg

Marque : TargetMol

Contactez votre distributeur local :


Téléphone : +1 850 650 7790

Mirvetuximab

(Synonyms: M9346A) Copy Product Info
Mirvetuximab (M9346A) is a novel folate receptor α (FRα) monoclonal antibody targeting anti-FOLR1 (folate receptor 1). Mirvetuximab soravtansine is often conjugated with platinum compounds or other compounds to form antibody-drug conjugates for the treatment of ovarian cancer and other FRα-positive cancers.
Mirvetuximab
Cas No. 1453084-36-0
For research use only—not for human use. No sales to individuals. Use as intended only.
Select Batch
Purity:> 95%
Appearance:Liquid
Color:Transparent

Product Information

Bioactivity
Description
Mirvetuximab (M9346A) is a novel folate receptor α (FRα) monoclonal antibody targeting anti-FOLR1 (folate receptor 1). Mirvetuximab soravtansine is often conjugated with platinum compounds or other compounds to form antibody-drug conjugates for the treatment of ovarian cancer and other FRα-positive cancers.
Endotoxin<1.0 EU/mg
SynonymsM9346A
Reactivity
Human
Verified Activity
Immobilized Human FRa Protein (ECD, His) at 2 μg/mL (30 μL/well) can bind Mirvetuximab. The EC50 is 9.298 ng/mL.
Mirvetuximab
Application
Functional assay
Antibody Type
Monoclonal
FormulationSupplied as a sterile solution in a buffered formulation system (e.g., phosphate-, citrate-, or amino acid-based). Please refer to the CoA for lot-specific composition.
Endotoxin<1.0 EU/mg
Related Conjugates and Formulations
Conjucates
Unconjugated
Antigen Details
Gene ID
2348
Uniprot ID
P15328
TargetFOLR1/FRA
Chemical Properties
Molecular Weight145.96 kDa
Cas No.1453084-36-0
Antibody Information
IsotypeHuman IgG1 kappa
Recommended Isotype Control
Human IgG1 kappa, Isotype Control
Storage & Solubility Information
StorageStore at low temperature -20°C for 1 year Shipping with blue ice/Shipping at ambient temperature.

Vous serez peut-être également intéressé par les produits suivants :